Top Story

Low testosterone may raise diabetes risk

May 1, 2016

In male mice, androgen receptor deficiency in beta cells impairs glucose-stimulated insulin secretion, increasing the risk for developing type 2 diabetes, according to recent study findings.

The study could help identify new treatments for type 2 diabetes in the large number of men with low testosterone due to age or prostate cancer therapies.

New studies evaluate Jardiance in patients with chronic heart failure

April 30, 2016
Two new outcome trials will investigate the SGLT2 inhibitor Jardiance for the treatment of people with chronic heart failure, Boehringer Ingelheim and Eli Lilly and…
In the Journals

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

April 29, 2016
In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking…
In the Journals

Urinary incontinence associated with type 1 diabetes in women

April 29, 2016
The odds of urinary incontinence increase with poor glycemic control in women with type 1 diabetes, according to recent study findings. Sara M. Lenherr, MD
In the Journals

Psoriasis associated with type 2 diabetes, obesity in twin study

April 29, 2016
Psoriasis had a strong association with type 2 diabetes and obesity in a nationwide study of Danish twins, indicating a common genetic etiology between psoriasis and…
More News Headlines »

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News Coverage

VIDEO: Testosterone Trials results announcement met with anticipation

April 7, 2016
More »
Highlights from ENDO 2016

Highlights from ENDO 2016

CME Video

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Current Issues
View the Current Issues